RaySearch Has Received New Regulatory Clearance For RayStation In China

Posted by RaySearch

RaySearch has received a new regulatory clearance from the Chinese authorities NMPA (previously CFDA) for the treatment planning system RayStation. With this clearance RaySearch can continue to supply the innovative and machine agnostic RayStation to customers in China.

RayStation is designed for multi-modality support of many different treatment delivery machines and is therefore well suited for the large and varied market in China, with many different types of treatment machines installed.

With its large population, China puts stringent requirement on speed and efficiency in the treatment process in order to offer advanced radiotherapy treatments to as many patients as possible. This also suits RayStation well, as it has a strong automation focus and can easily be scaled to fit each customer’s needs and requirements.

Johan Löf, founder and CEO of RaySearch, says: “We are pleased to have received this NMPA clearance so that we can provide RayStation to the radiotherapy market in China. RayStation, with its leading position in efficiency and performance, fits the rapidly growing demands from customers in China very well”.―CT Bureau